PharmaNest Presents NASH Digital Pathology and AI Results With a Performance That Compares to Histological Stages and Imaging Methods at the Liver Meeting® | AASLD 2022 PRINCETON, N.J., Nov. 03, 2022 (GLOBE NEWSWIRE) -- PharmaNest, an emerging leader in quantitative Digital Pathology and Artificial Intelligence, announces today that it will present, alongside with...

The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH PARIS, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) announced today that they have entered a strategic partnership that...

PharmaNest to Present Eight Digital Pathology and AI Abstracts at the International Liver Congress 2022 PRINCETON, N.J., June 20, 2022 (GLOBE NEWSWIRE) -- PharmaNest, an emerging leader in quantitative Digital Pathology and Artificial Intelligence, announces today that it will be present, alongside...